{"title":"Investigating causal relationships between plasma proteins and lung adenocarcinoma: result from proteomics and Mendelian randomization study.","authors":"Ruoya Lv, Jiabin Chen, Xiaoyu Wu, Kequn Chai, Jiadong Yan, Sheng Wang","doi":"10.1007/s12672-025-01778-y","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Plasma proteins contribute to the identification, diagnosis, and prognosis of human illnesses, which may be conducive to understanding the molecular mechanism and diagnosis of Lung adenocarcinoma (LUAD).</p><p><strong>Methods: </strong>We collected plasma samples from 28 healthy individuals (H) and 56 LUAD patients and analyzed them using LC-MS/MS-based proteomics to determine differential expression plasma proteins (DEPPs). Then, the DEPPs were subjected to a two-sample Mendelian randomization (MR) study based on an \"Inverse variance weighted (IVW)\" approach to investigate the causal relationships between DEPPs and LUAD. Logistic regression analysis was conducted to develop a diagnostic model for LUAD.</p><p><strong>Results: </strong>317 plasma proteins were found in proteomics, and 19 DEPPs were identified. The MR study revealed that IL20RB (odds ratio (OR) = 1.600, 95% Confidence Interval (CI) [1.098, 2.331], P = 0.014) and SAA2 (OR = 1.048, 95%CI [1.012, 1.081], P = 0.017) were highly related to LUAD. A diagnostic model was established with IL20RB and SAA2. The AUC of this diagnostic model was 0.858.</p><p><strong>Conclusion: </strong>Plasma IL20RB and SAA2 levels were closely connected with LUAD.</p>","PeriodicalId":11148,"journal":{"name":"Discover. Oncology","volume":"16 1","pages":"42"},"PeriodicalIF":2.8000,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11729587/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Discover. Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12672-025-01778-y","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Plasma proteins contribute to the identification, diagnosis, and prognosis of human illnesses, which may be conducive to understanding the molecular mechanism and diagnosis of Lung adenocarcinoma (LUAD).
Methods: We collected plasma samples from 28 healthy individuals (H) and 56 LUAD patients and analyzed them using LC-MS/MS-based proteomics to determine differential expression plasma proteins (DEPPs). Then, the DEPPs were subjected to a two-sample Mendelian randomization (MR) study based on an "Inverse variance weighted (IVW)" approach to investigate the causal relationships between DEPPs and LUAD. Logistic regression analysis was conducted to develop a diagnostic model for LUAD.
Results: 317 plasma proteins were found in proteomics, and 19 DEPPs were identified. The MR study revealed that IL20RB (odds ratio (OR) = 1.600, 95% Confidence Interval (CI) [1.098, 2.331], P = 0.014) and SAA2 (OR = 1.048, 95%CI [1.012, 1.081], P = 0.017) were highly related to LUAD. A diagnostic model was established with IL20RB and SAA2. The AUC of this diagnostic model was 0.858.
Conclusion: Plasma IL20RB and SAA2 levels were closely connected with LUAD.